UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Current treatment landscape and emerging therapies for metastatic triple-negative breast cancer

The American journal of managed care, 2021-04, Vol.27 (5 Suppl), p.S87-S96

Adel, Nelly G

2021

Volltextzugriff (PDF)

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center

Journal of clinical oncology, 2015-10, Vol.33 (28), p.3193-3198

2015

Volltextzugriff (PDF)

High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis

Journal of clinical oncology, 2011-09, Vol.29 (25), p.3466-3473

2011

Volltextzugriff (PDF)

Current treatment landscape and emerging therapies for pancreatic cancer

The American journal of managed care, 2019-01, Vol.25 (1 Suppl), p.S3-S10

Adel, Nelly

2019

Volltextzugriff (PDF)

Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death

Leukemia research, 2013-09, Vol.37 (9), p.1004-1009

2013

Volltextzugriff (PDF)

Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies

The American journal of managed care, 2017-09, Vol.23 (14 Suppl), p.S259-S265

Adel, Nelly

2017

Volltextzugriff (PDF)

Reply to A. Indini et al

Journal of clinical oncology, 2016-03, Vol.34 (9), p.1018-1019

2016

Volltextzugriff (PDF)

Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation

Biology of blood and marrow transplantation, 2015-05, Vol.21 (5), p.920-925

2015

Volltextzugriff (PDF)

Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Blood, 2016-12, Vol.128 (22), p.4623-4623

2016

Volltextzugriff (PDF)

Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia

Annals of hematology, 2016-12, Vol.95 (12), p.2009-2015

2016

Volltextzugriff (PDF)

Hypoalbuminemia Is Significantly Associated with Increased Clearance Time of High Doses of Methotrexate

Blood, 2015-12, Vol.126 (23), p.3711-3711

2015

Volltextzugriff (PDF)

Effects of Obesity on the Efficacy and Toxicity of Induction Chemotherapy in Adult Acute Lymphoblastic Leukemia (ALL)

Blood, 2015-12, Vol.126 (23), p.1290-1290

2015

Volltextzugriff (PDF)

Incidence and Management of Proteasome Inhibitor-Related Cardiotoxicity in Multiple Myeloma Patients at Memorial Sloan Kettering Cancer Center

Blood, 2015-12, Vol.126 (23), p.4265-4265

2015

Volltextzugriff (PDF)

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S191-S191

2017

Volltextzugriff (PDF)

Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia

Leukemia research, 2018-05, Vol.68, p.48-50

2018

Volltextzugriff (PDF)

Safety of pembrolizumab (pem) in patients (pts) who stopped ipilimumab (ipi) due to immune-related adverse events

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20023-e20023

2015

Volltextzugriff (PDF)

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency

Leukemia & lymphoma, 2017-05, Vol.58 (5), p.1123-1129

2017

Volltextzugriff (PDF)

Similar Incidence of Typhlitis in Patients Receiving Various Doses of Daunorubicin or Idarubicin As Induction for Acute Myeloid Leukemia

Blood, 2014-12, Vol.124 (21), p.3725-3725

2014

Volltextzugriff (PDF)

Impact Of Renal Insufficiency and Obesity On Safety and Outcomes Of BEAM Conditioning

Blood, 2013-11, Vol.122 (21), p.3281-3281

2013

Volltextzugriff (PDF)

Outcomes Of Tyrosine Kinase Inhibitors In Combination With Various Treatments Regimens In Adult Patients With Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

Blood, 2013-11, Vol.122 (21), p.2644-2644

2013

Volltextzugriff (PDF)

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Blood, 2016-12, Vol.128 (22), p.2219-2219

2016

Volltextzugriff (PDF)

Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients

Journal of oncology pharmacy practice, 2009-09, Vol.15 (3), p.175-182

2009

Volltextzugriff (PDF)

Efficacy and Risk Factors Analysis of Upfront Autologous Stem Cell Mobilization Using Plerixafor and Granulocyte-Colony Stimulating Factor (GCSF) in Patients with Multiple Myeloma

Blood, 2014-12, Vol.124 (21), p.3856-3856

2014

Volltextzugriff (PDF)

Upfront Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients: An Update on Cost Analysis Study at Memorial Sloan Kettering Cancer Center

Blood, 2014-12, Vol.124 (21), p.848-848

2014

Volltextzugriff (PDF)

Cryotherapy Reduces Mucositis in Multiple Myeloma Patients Receiving High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation

Blood, 2012-11, Vol.120 (21), p.4265-4265

2012

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(65)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(18)
Humans
(12)
Female
(11)
Male
(11)
Aged
(9)
Middle Aged
(9)
Adult
(8)
Oncology
(7)
Retrospective Studies
(7)
Aged, 80 And Over
(6)
Hematology
(6)
Risk Factors
(6)
Adolescent
(5)
Antineoplastic Agents - Adverse Effects
(5)
Hematology, Oncology And Palliative Medicine
(5)
General & Internal Medicine
(4)
Medicine, General & Internal
(4)
Treatment Outcome
(4)
Young Adult
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Current treatment landscape and emerging therapies for metastatic triple-negative breast cancer

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center

High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis

Current treatment landscape and emerging therapies for pancreatic cancer

Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death

Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies

Reply to A. Indini et al

Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation

Outcomes of Rituximab for EBV Viremia/Post-Transplant Lymphoproliferative Disease in CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation

Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia

Hypoalbuminemia Is Significantly Associated with Increased Clearance Time of High Doses of Methotrexate

Effects of Obesity on the Efficacy and Toxicity of Induction Chemotherapy in Adult Acute Lymphoblastic Leukemia (ALL)

Incidence and Management of Proteasome Inhibitor-Related Cardiotoxicity in Multiple Myeloma Patients at Memorial Sloan Kettering Cancer Center

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia

Safety of pembrolizumab (pem) in patients (pts) who stopped ipilimumab (ipi) due to immune-related adverse events

Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency

Similar Incidence of Typhlitis in Patients Receiving Various Doses of Daunorubicin or Idarubicin As Induction for Acute Myeloid Leukemia

Impact Of Renal Insufficiency and Obesity On Safety and Outcomes Of BEAM Conditioning

Outcomes Of Tyrosine Kinase Inhibitors In Combination With Various Treatments Regimens In Adult Patients With Philadelphia Chromosome Positive Acute Lymphocytic Leukemia

Incidence, Severity, Day 100 Treatment Efficacy and Therapy Toxicity of Cytomegalovirus (CMV) Infections with Early Pre-Emptive Therapy in Adult Cord Blood (CB) Transplant Recipients

Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients

Efficacy and Risk Factors Analysis of Upfront Autologous Stem Cell Mobilization Using Plerixafor and Granulocyte-Colony Stimulating Factor (GCSF) in Patients with Multiple Myeloma

Upfront Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients: An Update on Cost Analysis Study at Memorial Sloan Kettering Cancer Center

Cryotherapy Reduces Mucositis in Multiple Myeloma Patients Receiving High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation

Suchergebnisse filtern